For the Inventor, By the Inventor

Enter assignee name

Prague, Czechia

Zentiva K.s.

USPTO Granted Patents = 20

EPO Patents = 59

Forward Citations = 5

Loading Chart...

Loading Chart...

45 inventors (with patents filed for the assignee):

Jindrich Richter (6 out of 9 patents)

Ludek Ridvan (6 out of 7 patents)

Ondrej Dammer (4 out of 5 patents)

4. Josef Jirman (4 out of 7 patents)

5. Lukas Placek (4 out of 4 patents)

6. Kamal Jarrah (3 out of 3 patents)

7. Tomas Pekarek (3 out of 3 patents)

8. Petr Lustig (3 out of 4 patents)

9. Monika Zatopkova (3 out of 3 patents)

10. Josef Hajicek (3 out of 4 patents)

11. Karel Ulbrich (2 out of 5 patents)

12. Stanislav Radl (2 out of 2 patents)

13. Lukas Krejcik (2 out of 2 patents)

14. Tomas Etrych (2 out of 3 patents)

15. Blanka Rihova (2 out of 4 patents)

20 patents: Sort by Forward Citations

1. 10532981 - Crystalline modifications of methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}phenyl)amino](phenyl)methylidene}-2-oxo-2,3-dihydro-1H-indole-6-carboxylate salts and methods of preparation thereof (2020-01-14),

2. 10457671 - Crystalline form of Canagliflozin and a method of its preparation (2019-10-29),

3. 10125122 - Method for preparing methyl (Z)-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene)oxindole-6-carboxylate (intedanib, nintedanib) (2018-11-13),

4. 9920021 - Method of preparing vortioxetine (2018-03-20),

5. 9862723 - Stable polymorph of the salt of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-α]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-anime with L-tartaric acid (2018-01-09),

6. 8927771 - Pharmaceutically acceptable cocrystals of N-[2-(7-methoxyl-1-naphtyl)ethyl]acetamide and methods of their preparation (2015-01-06),

7. 8779005 - Salts of desvenlafaxine and a method of their preparation (2014-07-15),

8. 8603990 - Grafted macromolecular conjugates of doxorubicin with anticancer activity and method of their preparation (2013-12-10),

9. 8394962 - Method for the preparation of dabigatran and its intermediates (2013-03-12),

10. 8394961 - Method for the preparation of dabigatran (2013-03-12),

11. 8207356 - Method for the preparation of (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine) (2012-06-26),

12. 8143417 - Method for the preparation of zolmitriptan (2012-03-27),

13. 8071791 - [object Object] (2011-12-06),

14. 8034942 - Process for the preparation of solifenacin (2011-10-11),

15. 8034807 - Salts of bazedoxifene (2011-10-11),

Zentiva k.s. is a leading global pharmaceutical company focused on developing, manufacturing, and commercializing high-quality and affordable generic medicines. With a strong heritage dating back over 100 years, Zentiva is committed to improving access to healthcare by providing safe and effective treatments to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

20 Patents

#7 in Prague

#20 in Czechia

#30,325 in the World

Prague, Czechia

Zentiva K.s.

Forward Citations = 5

45 inventors:

Jindrich Richter (6 out of 9 patents)

Ludek Ridvan (6 out of 7 patents)

Ondrej Dammer (4 out of 5 patents)

4. Josef Jirman (4 out of 7 patents)

5. Lukas Placek (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…